Kestra Medical Technologies Ltd reports results for the quarter ended April 30 - Earnings Summary

• Kestra Medical Technologies Ltd KMTS reported a quarterly adjusted loss of $2.21​​ per share for the quarter ended April 30. The mean expectation of six analysts for the quarter was for a loss of 52 cents per share. Wall Street expected results to range from -65 cents to -46 cents per share.

• Revenue was $17.23 million​; analysts expected $15.75 million.

• Kestra Medical Technologies Ltd's reported EPS for the quarter was a loss of $2.21​.

• The company reported a quarterly loss of $54.4 million.

• Kestra Medical Technologies Ltd shares had fallen by 6.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $28.00, about 44.9% above its last closing price of $15.43

This summary was machine generated from LSEG data July 15 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)